After digging into almost a dozen whistleblower complaints alleging pharma companies ran kickback schemes with nurse educators as the "payment"—so-called white-coat marketing—the government is backing out.
After digging into almost a dozen whistleblower complaints alleging pharma companies ran kickback schemes with nurse educators as the "payment"—so-called white-coat marketing—the government is backing out.
FDA Commissioner Scott Gottlieb, M.D., hasn’t been shy about allying with President Donald Trump on the subject of high drug prices. Even though pricing is not the FDA's purview, Gottlieb has vowed to do ...